SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-16-038450
Filing Date
2016-09-08
Accepted
2016-09-07 18:15:45
Documents
5
Period of Report
2016-06-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atrn20160907_8k.htm 8-K 27181
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 2060
3 a3.jpg GRAPHIC 336546
4 a2.jpg GRAPHIC 229991
5 a1.jpg GRAPHIC 235361
  Complete submission text file 0001437749-16-038450.txt   1135120
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 161874423
SIC: 7389 Services-Business Services, NEC